{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:07:22Z","timestamp":1790888842531,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1053\/j.ajkd.2020.04.016","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T21:07:28Z","timestamp":1595452048000},"page":"280-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":201,"title":["Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics"],"prefix":"10.1053","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1828-2387","authenticated-orcid":false,"given":"Milton","family":"Packer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1053\/j.ajkd.2020.04.016_bib1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(19)30256-6","article-title":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"7","author":"Neuen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"24","key":"10.1053\/j.ajkd.2020.04.016_bib2","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2020.04.016_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215362","article-title":"Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: a meta-analysis","volume":"14","author":"Wang","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1053\/j.ajkd.2020.04.016_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in\u00a0patients with type 1 diabetes mellitus","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ajkd.2020.04.016_bib5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.kint.2019.09.013","article-title":"The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial","volume":"97","author":"van Bommel","year":"2020","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2020.04.016_bib6","doi-asserted-by":"crossref","first-page":"F194","DOI":"10.1152\/ajprenal.00520.2013","article-title":"SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice","volume":"306","author":"Vallon","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.04.016_bib7","doi-asserted-by":"crossref","first-page":"E287","DOI":"10.1152\/ajpendo.00308.2010","article-title":"Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes","volume":"300","author":"Zhang","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2020.04.016_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2337\/diab.38.1.75","article-title":"Kidney hemodynamics after ketone body and amino acid infusion in normal and IDDM subjects","volume":"38","author":"Nosadini","year":"1989","journal-title":"Diabetes"},{"issue":"8","key":"10.1053\/j.ajkd.2020.04.016_bib9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCULATIONAHA.119.044235","article-title":"Effect of empagliflozin on erythropoietin levels, iron stores and red blood cell morphology in patients with type 2 diabetes and coronary artery disease","volume":"141","author":"Mazer","year":"2020","journal-title":"Circulation"},{"issue":"21","key":"10.1053\/j.ajkd.2020.04.016_bib10","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2020.04.016_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2362.2005.01525.x","article-title":"Regulation of erythropoietin production","volume":"35","author":"Eckardt","year":"2005","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1053\/j.ajkd.2020.04.016_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MNH.0000000000000341","article-title":"Hypoxia-inducible factor activation in diabetic kidney disease","volume":"26","author":"Persson","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"10.1053\/j.ajkd.2020.04.016_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ki.2009.460","article-title":"Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization","volume":"77","author":"Paliege","year":"2010","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2020.04.016_bib14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1172\/JCI30117","article-title":"Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo","volume":"117","author":"Rankin","year":"2007","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1053\/j.ajkd.2020.04.016_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","article-title":"HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption","volume":"3","author":"Papandreou","year":"2006","journal-title":"Cell Metab"},{"issue":"11","key":"10.1053\/j.ajkd.2020.04.016_bib16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1813599","article-title":"Roxadustat for anemia in patients with kidney disease not receiving dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2020.04.016_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/jpet.119.258731","article-title":"TP0463518, a novel prolyl hydroxylase inhibitor, specifically induces erythropoietin production in the liver","volume":"371","author":"Kato","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1053\/j.ajkd.2020.04.016_bib18","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/ndt\/gfm715","article-title":"Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model","volume":"23","author":"Ohtomo","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2020.04.016_bib19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1006\/bbrc.2001.5835","article-title":"Hypoxia-inducible factor 2alpha binds to cobalt in vitro","volume":"288","author":"Yuan","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1053\/j.ajkd.2020.04.016_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/jcmm.13319","article-title":"Impaired erythropoietin synthesis in chronic kidney disease is caused by alterations in extracellular matrix composition","volume":"22","author":"Olmos","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1053\/j.ajkd.2020.04.016_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fcell.2015.00042","article-title":"Hypoxia signaling pathways: modulators of oxygen-related organelles","volume":"3","author":"Sch\u00f6nenberger","year":"2015","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.04.016_bib22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cmet.2014.09.017","article-title":"HIF-2\u03b1 promotes degradation of mammalian peroxisomes by selective autophagy","volume":"20","author":"Walter","year":"2014","journal-title":"Cell Metabolism"},{"key":"10.1053\/j.ajkd.2020.04.016_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40200-017-0331-5","article-title":"Carbohydrate restriction ameliorates nephropathy by reducing oxidative stress and upregulating HIF-1\u03b1 levels in type-1 diabetic rats","volume":"16","author":"Krishan","year":"2017","journal-title":"J Diabetes Metab Disord"},{"issue":"4","key":"10.1053\/j.ajkd.2020.04.016_bib24","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1681\/ASN.2006060639","article-title":"Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney","volume":"18","author":"Kojima","year":"2007","journal-title":"JASN"},{"issue":"6","key":"10.1053\/j.ajkd.2020.04.016_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cmet.2005.05.002","article-title":"Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation","volume":"1","author":"Brunelle","year":"2005","journal-title":"Cell Metobolism"},{"issue":"1","key":"10.1053\/j.ajkd.2020.04.016_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1423-0127-19-7","article-title":"Ischemic preconditioning reduces endoplasmic reticulum stress and upregulates hypoxia inducible factor-1\u03b1 in ischemic kidney: the role of nitric oxide","volume":"19","author":"Mahfoudh-Boussaid","year":"2012","journal-title":"J Biomed Sci"},{"issue":"4","key":"10.1053\/j.ajkd.2020.04.016_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096117","article-title":"Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes","volume":"9","author":"Bai","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1053\/j.ajkd.2020.04.016_bib28","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2337\/db15-0519","article-title":"HIF-1 mediates renal fibrosis in OVE26 type 1 diabetic mice","volume":"65","author":"Nayak","year":"2016","journal-title":"Diabetes"},{"issue":"4","key":"10.1053\/j.ajkd.2020.04.016_bib29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.kint.2016.05.026","article-title":"Hypoxia-inducible factor-1\u03b1 promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3","volume":"90","author":"Baumann","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2020.04.016_bib30","first-page":"15878","article-title":"Hypoxia inducible factor-1\u03b1 mediates the profibrotic effect of albumin in renal tubular cells","volume":"7","author":"Hu","year":"2017","journal-title":"FASEB"},{"issue":"1","key":"10.1053\/j.ajkd.2020.04.016_bib31","doi-asserted-by":"crossref","first-page":"11351","DOI":"10.1038\/s41598-017-11829-2","article-title":"Selective tubular activation of hypoxia-inducible factor-2\u03b1 has dual effects on renal fibrosis","volume":"7","author":"Kong","year":"2017","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1053\/j.ajkd.2020.04.016_bib32","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1172\/JCI69073","article-title":"Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury","volume":"124","author":"Kapitsinou","year":"2014","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1053\/j.ajkd.2020.04.016_bib33","doi-asserted-by":"crossref","first-page":"F1343","DOI":"10.1152\/ajprenal.00007.2015","article-title":"Modeling oxygen consumption in the proximal tubule: effects of NHE and SGLT2 inhibition","volume":"308","author":"Layton","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ajkd.2020.04.016_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fphys.2017.00385","article-title":"Renal oxygenation in the pathophysiology of chronic kidney disease","volume":"8","author":"Liu","year":"2017","journal-title":"Front Physiol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.04.016_bib35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/HYPERTENSIONAHA.113.01425","article-title":"Kidney hypoxia, attributable to increased oxygen consumption, induces nephropathy independently of hyperglycemia and oxidative stress","volume":"62","author":"Friederich-Persson","year":"2013","journal-title":"Hypertension"},{"issue":"9","key":"10.1053\/j.ajkd.2020.04.016_bib36","doi-asserted-by":"crossref","first-page":"F807","DOI":"10.1152\/ajprenal.00049.2016","article-title":"Pronounced kidney hypoxia precedes albuminuria in type 1 diabetic mice","volume":"310","author":"Franz\u00e9n","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1105","key":"10.1053\/j.ajkd.2020.04.016_bib37","doi-asserted-by":"crossref","first-page":"20190562","DOI":"10.1259\/bjr.20190562","article-title":"Non-invasive assessment of early stage diabetic nephropathy by DTI and BOLD MRI","volume":"93","author":"Feng","year":"2020","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.04.016_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjms.2019.11.004","article-title":"Renal lipid metabolism and lipotoxicity in diabetes","volume":"359","author":"Thongnak","year":"2020","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1053\/j.ajkd.2020.04.016_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s13105-015-0424-x","article-title":"Advanced oxidation protein products induce apoptosis in podocytes through induction of endoplasmic reticulum stress","volume":"71","author":"Rong","year":"2015","journal-title":"J Physiol Biochem"},{"issue":"1","key":"10.1053\/j.ajkd.2020.04.016_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nephro.2018.04.002","article-title":"Intracellular organelles in health and kidney disease","volume":"15","author":"Shamekhi Amiri","year":"2019","journal-title":"Nephrol Ther"},{"issue":"4","key":"10.1053\/j.ajkd.2020.04.016_bib41","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00018-017-2639-1","article-title":"Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential","volume":"75","author":"Yang","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"10.1053\/j.ajkd.2020.04.016_bib42","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"issue":"8","key":"10.1053\/j.ajkd.2020.04.016_bib43","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00125-003-1155-z","article-title":"Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension","volume":"46","author":"Palm","year":"2003","journal-title":"Diabetologia"},{"issue":"11","key":"10.1053\/j.ajkd.2020.04.016_bib44","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1210\/me.2013-1036","article-title":"Advanced glycated end-products affect HIF-transcriptional activity in renal cells","volume":"27","author":"Bondeva","year":"2013","journal-title":"Mol Endocrinol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.04.016_bib45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ki.2010.99","article-title":"High glucose activates HIF-1-mediated signal transduction in glomerular mesangial cells through a carbohydrate response element binding protein","volume":"78","author":"Isoe","year":"2010","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2020.04.016_bib46","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/dom.13961","article-title":"Interplay of adenosine monophosphate-activated protein kinase\/sirtuin-1 activation and sodium influx inhibition mediates the renal benefits of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: a novel conceptual framework","volume":"22","author":"Packer","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1053\/j.ajkd.2020.04.016_bib47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.04.016_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14348\/molcells.2016.2318","article-title":"Sirt1 and the mitochondria","volume":"39","author":"Tang","year":"2016","journal-title":"Mol Cells"},{"issue":"3","key":"10.1053\/j.ajkd.2020.04.016_bib49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2337\/db15-0473","article-title":"Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy","volume":"65","author":"Tagawa","year":"2016","journal-title":"Diabetes"},{"issue":"33","key":"10.1053\/j.ajkd.2020.04.016_bib50","doi-asserted-by":"crossref","first-page":"20499","DOI":"10.1074\/jbc.M115.666354","article-title":"Autophagy-lysosome pathway in renal tubular epithelial cells is disrupted by advanced glycation end products in diabetic nephropathy","volume":"290","author":"Liu","year":"2015","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1053\/j.ajkd.2020.04.016_bib51","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.kint.2017.12.008","article-title":"Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury","volume":"93","author":"Hong","year":"2018","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2020.04.016_bib52","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1080\/15548627.2015.1049799","article-title":"Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis","volume":"11","author":"Lenoir","year":"2015","journal-title":"Autophagy"},{"issue":"6","key":"10.1053\/j.ajkd.2020.04.016_bib53","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.molcel.2010.05.023","article-title":"Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha","volume":"38","author":"Lim","year":"2010","journal-title":"Mol Cell"},{"issue":"4","key":"10.1053\/j.ajkd.2020.04.016_bib54","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbrc.2006.02.088","article-title":"AMPK activation inhibits the expression of HIF-1alpha induced by insulin and IGF-1","volume":"342","author":"Treins","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"5932","key":"10.1053\/j.ajkd.2020.04.016_bib55","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1126\/science.1169956","article-title":"Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1","volume":"324","author":"Dioum","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1053\/j.ajkd.2020.04.016_bib56","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.1038\/s41598-019-51343-1","article-title":"Hypoxia-inducible factor-1\u03b1 is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy","volume":"9","author":"Bessho","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1053\/j.ajkd.2020.04.016_bib57","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1038\/s41598-018-25054-y","article-title":"High basolateral glucose increases sodium-glucose cotransporter 2 and reduces sirtuin-1 in renal tubules through glucose transporter-2 detection","volume":"8","author":"Umino","year":"2018","journal-title":"Scientific Reports"},{"issue":"13","key":"10.1053\/j.ajkd.2020.04.016_bib58","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1074\/jbc.M117.779520","article-title":"SGLT2 protein expression is increased in human diabetic nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice","volume":"292","author":"Wang","year":"2017","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1053\/j.ajkd.2020.04.016_bib59","doi-asserted-by":"crossref","first-page":"F1078","DOI":"10.1152\/ajprenal.00615.2018","article-title":"Prompt apoptotic response to high glucose in SGLT-expressing renal cells","volume":"316","author":"Nilsson","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.04.016_bib60","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/dmrr.2407","article-title":"Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis","volume":"29","author":"Maeda","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"10.1053\/j.ajkd.2020.04.016_bib61","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1055\/s-0034-1395609","article-title":"Empagliflozin, an inhibitor of sodium-glucose cotransporter 2 exerts anti-inflammatory and antifibrotic effects on experimental diabetic nephropathy partly by suppressing AGEs-receptor axis","volume":"47","author":"Ojima","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1053\/j.ajkd.2020.04.016_bib62","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1038\/s41598-018-22229-5","article-title":"Comprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in mice","volume":"8","author":"Kamezaki","year":"2018","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1053\/j.ajkd.2020.04.016_bib63","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1074\/jbc.M113.526814","article-title":"Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) protein diminishes sodium glucose transport 1 (SGLT1) and SGLT2 protein expression in renal epithelial tubular cells (LLC-PK1) under hypoxia","volume":"289","author":"Zapata-Morales","year":"2014","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1053\/j.ajkd.2020.04.016_bib64","doi-asserted-by":"crossref","first-page":"F969","DOI":"10.1152\/ajprenal.00551.2017","article-title":"SGLT2 inhibition in a kidney with reduced nephron number: modeling and analysis of solute transport and metabolism","volume":"314","author":"Layton","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"23","key":"10.1053\/j.ajkd.2020.04.016_bib65","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1042\/CS20190863","article-title":"Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats","volume":"133","author":"Swe","year":"2019","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1053\/j.ajkd.2020.04.016_bib66","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0006-291X(03)00453-4","article-title":"Differential regulation of HIF-1 alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells","volume":"303","author":"Cioffi","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"37","key":"10.1053\/j.ajkd.2020.04.016_bib67","doi-asserted-by":"crossref","first-page":"38458","DOI":"10.1074\/jbc.M406026200","article-title":"Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor","volume":"279","author":"Appelhoff","year":"2004","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1053\/j.ajkd.2020.04.016_bib68","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/labinvest.3700328","article-title":"Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model","volume":"85","author":"Tanaka","year":"2005","journal-title":"Lab Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2020.04.016_bib69","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1681\/ASN.2013090990","article-title":"Activation of hypoxia-inducible factors prevents diabetic nephropathy","volume":"26","author":"Nordquist","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2020.04.016_bib70","first-page":"114","article-title":"Hypoxia initiates sirtuin1-mediated vascular endothelial growth factor activation in choroidal endothelial cells through hypoxia inducible factor-2\u03b1","volume":"18","author":"Balaiya","year":"2012","journal-title":"Mol Vis"},{"issue":"3","key":"10.1053\/j.ajkd.2020.04.016_bib71","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/NHA-170022","article-title":"A central role for hypoxia-inducible factor (HIF)-2\u03b1 in hepatic glucose homeostasis","volume":"4","author":"Ramakrishnan","year":"2017","journal-title":"Nutr Healthy Aging"},{"issue":"2","key":"10.1053\/j.ajkd.2020.04.016_bib72","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10534-006-9020-4","article-title":"Chronic cobalt treatment decreases hyperglycemia in streptozotocin-diabetic rats","volume":"20","author":"Vasudevan","year":"2007","journal-title":"Biometals"},{"issue":"3","key":"10.1053\/j.ajkd.2020.04.016_bib73","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1681\/ASN.2019060582","article-title":"Prolyl hydroxylase domain inhibitor protects against metabolic disorders and associated kidney disease in obese type 2 diabetic mice","volume":"31","author":"Sugahara","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.04.016_bib74","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.kint.2019.12.007","article-title":"The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease","volume":"97","author":"Hasegawa","year":"2020","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2020.04.016_bib75","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/jcmm.13117","article-title":"Ablation of endothelial prolyl hydroxylase domain protein-2 promotes renal vascular remodelling and fibrosis in mice","volume":"21","author":"Wang","year":"2017","journal-title":"J Cell Mol Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620308490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620308490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:31:38Z","timestamp":1759462298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638620308490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0272638620308490"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.04.016","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}